Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes-Associated Protein 1 Activation and Transient Expansion of Stem-Like Cancer Cells

By
Justin.choi
-
0
45
Treatment effects on tumor-initiating cells were estimated by sphere-forming capacity in vitro, tumorigenicity in vivo, and flow cytometry.
[Hepatology Communications]
Abstract